Not every drug is right for every person, so its essential to consider your options with a clinician
Always consult a licensed healthcare professional
Contact an OB-GYN or clinician for missed periods, bleeding after menopause, or persistent cycle changes
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
Sculptra for Long-Term Collagen Support Sculptra works gradually by stimulating your bodys natural collagen production, rebuilding structure and elasticity from within
The first ingredient, dapagliflozin, belongs to a class of drugs called SGLT2 inhibitors